Korean J Med.
1998 Apr;54(4):494-501.
Endoscopic Mucosal Resection for Premalignant Lesions and Early Gastric Cancer
- Affiliations
-
- 1Department of Internal Medicine, Wonju College of Medicine, Yonsei University, Wonju, Korea.
Abstract
OBJECTIVES
Gastrectomy with lymph node dissec
tion is the standard treatment for early gastric can
cer(EGC). However, patients who have high risks demand
modifications in surgical treatment for EGC. Recently,
endoscopic mucosal resection(EMR) has become accepted
in many institutions as a treatment for cancerous mucosal
lesions of the stomach. Thus we investigated the efficacy
and safety of EMR prospectively in the patients with
EGC who have high risks in surgery and those with
premalignant lesions.
METHOD: Twenty-five patients were treated with
EMR, thirteen were EGC and twelve were premalignant
lesions such as tubular adenoma, severe dysplasia. We
used standard snare method and endoscopic mucosal
resection using a band ligation kits(EMRL).
RESULTS
The complete resection rate at the first step
of EMR was 100%(12/12) in premalignant lesions,
76.9%(10/13) in EGC. Of three EGC resected incomple
tely at the first step, one patient was treated by surgery
and two patients underwent the third step of EMR. The
final complete resection rate was 92%(23/25) and it was
100%(12/12) in the premalignant lesions, 84.6%(11/13) in
EGC. The final complete resection rate in according to
the methods was 100%(5/5) by standard snare method,
75%(6/8) by EMRL. As pathologic results, all cases of
EGC were limited to the mucosa. No serious complications
such as perforation, major bleeding were encountered.
CONCLUSION
We consider that EMR is effective and
safe in treatment of the patients with EGC who have high
risks in surgery and those with premalignant lesions.